Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pacific Horizon Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 8
Rounds per year 0.39
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.27
Exits 3
Key employees 1
Stages of investment
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Therapeutics
  • Medical
  • Diabetes
Summary

In 1993 was created Pacific Horizon Ventures, which is appeared as VC. The main office of represented VC is situated in the Seattle. The company was established in North America in United States.

Besides them, we counted 1 critical employee of this fund in our database.

The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Inhibitex, iScience Interventional, Koronis Pharmaceuticals. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Pacific Horizon Ventures, startups are often financed by Asset Management Ventures (AMV), Prism Venture Management, DeNovo Ventures. The meaningful sponsors for the fund in investment in the same round are Asset Management Ventures (AMV), Prism Venture Management, DeNovo Ventures. In the next rounds fund is usually obtained by Prism Venture Management, Three Arch Partners, DeNovo Ventures.

The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2011. The high activity for fund was in 2007. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Pacific Horizon Ventures performs on 7 percentage points less the average number of lead investments. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pacific Horizon Ventures:
Typical Co-investors
Pacific Horizon Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pacific Horizon Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Blindspot Canada, Ontario, Toronto
CAR Inc. Beijing, Beijing, China
CM Diamant -
Defence and Security Accelerator -
Early-Stage NYC Fund New York, New York, United States
Gateway California, Oakland, United States
Gelita AG Baden-Württemberg, Baden-Wurttemberg, Germany
Grupo RPP -
High Alpha Indiana, Indianapolis, United States
Institutional Investor New York, New York, United States
Kataweb Italy, Lazio, Rome
KohFounders California, Los Angeles, United States
Laurier Start-up Fund Canada, Ontario, Waterloo
Nippon Broadcasting System Chiyoda, Japan
NorthStar Capital Minneapolis, Minnesota, United States
Okta California, San Francisco, United States
QSP -
Sallie Mae Delaware, Newark, United States
Sapphire Lake Investment Beijing, Beijing, China
Vision Brazil Investments Brazil, Espirito Santo, Pernambuco

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ViaCyte

Biotechnology
Diabetes
Drug Discovery
Health Care
Medical
Therapeutics
$25M16 Jul 2007 San Diego, California, United States

iScience Surgical

Biotechnology
Health Care
Life Science
$15M31 Mar 2005 California, United States

TransMolecular

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$33M01 Mar 2004 Birmingham, Alabama, United States

iScience Interventional

Biotechnology
Health Care
Health Diagnostics
$7M18 Mar 2003 California, United States

iScience Surgical

Biotechnology
Health Care
Life Science
$7M17 Mar 2003 California, United States

TransMolecular

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$9M14 Sep 2000 Birmingham, Alabama, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pacific Horizon Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 16M
Rounds per year 0.39
Peak activity year 2007
Lead investments 2
Follow on index 0.27
Exits 3
Group Appearance index 0.82

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ViaCyte

Biotechnology
Diabetes
Drug Discovery
Health Care
Medical
Therapeutics
$25M16 Jul 2007 San Diego, California, United States

iScience Surgical

Biotechnology
Health Care
Life Science
$15M31 Mar 2005 California, United States

TransMolecular

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$33M01 Mar 2004 Birmingham, Alabama, United States

iScience Interventional

Biotechnology
Health Care
Health Diagnostics
$7M18 Mar 2003 California, United States

iScience Surgical

Biotechnology
Health Care
Life Science
$7M17 Mar 2003 California, United States

TransMolecular

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$9M14 Sep 2000 Birmingham, Alabama, United States
Crunchbase icon

Content report

The following text will be sent to our editors: